NR4A1 and breast carcinoma: Notably, no statistically significant disparities were observed among these three groups in age at diagnosis, different age groups, lymph node status, histological grade, bilateral breast cancer occurrence, LVI status, hormone receptor status, Ki-67 index, or the receipt of endocrine and targeted therapies.